Table: SymBio Pharmaceuticals -2018 parent results

SymBio Pharmaceuticals

07/02/2019 06:30

Feb 7 (Reuters)- 
          SymBio Pharmaceuticals Limited 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended        Year to        NEXT   
              Dec 31, 2018    Dec 31, 2017    Dec 31, 2019      YEAR     
                 LATEST         YEAR-AGO         COMPANY       COMPANY   
                 RESULTS         RESULTS        FORECAST     H1 FORECAST 
  Sales           3.84            3.44            4.47                   
               (+11.4 pct)     (+45.4 pct)     (+16.4 pct)               
  Operating     loss 2.66       loss 3.95       loss 3.59                
  Recurring     loss 2.75       loss 3.98       loss 3.61                
  Net           loss 2.75       loss 3.98       loss 3.62                
  EPS        loss 41.38 yen  loss 79.78 yen  loss 43.88 yen              
  Ann Div          NIL             NIL             NIL                   
  -Q2 Div          NIL             NIL             NIL                   
  -Q4 Div          NIL             NIL             NIL                   
  
  NOTE - SymBio Pharmaceuticals Limited. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T